Zevra Therapeutics (ZVRA) Return on Capital Employed Growth (5y) (2020 - 2026)
Zevra Therapeutics (ZVRA) Return on Capital Employed Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Zevra Therapeutics | 569.42 Mn | 368.80 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,332.00 |
| Dec 31, 2025 | 12,638.00 |
| Sep 30, 2025 | -4,851.00 |
| Jun 30, 2025 | -6,797.00 |
| Mar 31, 2025 | -6,777.00 |
| Dec 31, 2024 | 26,678.00 |
| Sep 30, 2024 | 92,676.00 |
| Jun 30, 2024 | 310,696.00 |
| Mar 31, 2024 | 60,202.00 |
| Dec 31, 2023 | 46,009.00 |
| Sep 30, 2023 | 63,741.00 |
| Dec 31, 2022 | 3,650.00 |
| Sep 30, 2022 | 3,239.00 |
| Jun 30, 2022 | 150.00 |
| Dec 31, 2021 | 5,103.00 |
| Sep 30, 2021 | 4,162.00 |
| Jun 30, 2021 | 3,744.00 |
| Mar 31, 2021 | 4,548.00 |
| Dec 31, 2020 | -10,687.00 |
| Sep 30, 2020 | 5,178.00 |